loading

7.30 – 9.00:  Breakfast

9.00 – 10.45: p53 and Family Members (Eric Eldering and Arturo Sala)

Jerry Chipuk: Direct Activation Of Bax By p53 Mediates Mitochondrial Membrane Permeabilization And Apoptosis.

W. Brent Derry: Assembling the p53 network in C. elegans by functional genomics.

Anastasis Stephanou: STAT1: a novel regulator of the apoptotic programme.

Miriam Erlacher: PUMA/bbc3, a key mediator of p53-induced apoptosis.

Hakan Akca: Cytokine-mediated induction of p53 and p21 is suppressed by EGF and insulin .

Vincenzo De Laurenzi: Identification of proteins regulating p73 function.

 

10.45 – 11.15: Coffee break

11.15 – 13.15: Cancer I (Michel Hahne and Brent Derry)

Peter Daniel: Synergy between TRAIL and DNA damaging tumor therapies depends on Bax but not Bak.

Monica Zerilli: Th2 cytokines induce chemotherapy resistance in epithelial tumors via PI3K/AKT pathway.

Engin Ulukaya: Response of lung cancer patients to cisplatin-based anti-cancer treatments: Effects on the levels of cleaved cytokeratin 18 and sFas .

Kerstin Bellmann: The counteracting roles of the kinases Akt/PKB and p38 in c-Myc dependent apoptosis.

Emma Sanzari: PED controls B-chronic lymphocytic leukaemia cell apoptosis

Arturo Sala: B-MYB regulates the stress response though direct transactivation of key survival genes.

Satoshi Inoue: Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies.

 

13.15 – 15.00: Lunch

15.00-16.30: Free Time

16.30-18.00: Cancer II (Peter Daniel and Engin Ulukaya)

Lourdes Planelles: Development of hyperplasia in aged APRIL transgenic mice.

Paul Chen: A Role for BAFF in Tumour Immunity.

Tobias Haas: Caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

Eric Eldering: CD40 stimulation increases both the anti- and pro-apoptotic protein profile of B-CLL cells and renders them sensitive to autologous CTL-attack.

Till Wenger: Lentiviral expression of TRAIL in human tumor cells.

 

18.00-20.00: Posters 29-55

20.00: Dinner